首页> 外文期刊>Urology >Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up.
【24h】

Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up.

机译:腹腔镜单点根治性膀胱切除术和盆腔淋巴结清扫术:初步经验和2年的随访。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To report the first series of laparoendoscopic single-site surgery for radical cystectomy and bilateral pelvic lymph node dissection. The development of laparoendoscopic single-site surgery and its application to urothelial malignancy has not been previously evaluated. METHODS: A novel, single multichannel port and flexible laparoscopic instruments and laparoscope were used for all procedures. The eligible patients had transitional cell carcinoma that was muscle invasive or refractory to intravesical therapy. Locally advanced disease, previous abdominal or pelvic surgery or radiotherapy, or those desiring orthotopic reconstruction were excluded. No additional ports were needed, and lymphadenectomy was performed using an extended template up to the aortic bifurcation. RESULTS: A total of 3 patients (2 men and 1 woman) underwent radical cystectomy with bilateral pelvic lymph node dissection. All the procedures were completed successfully. All patients underwent extracorporeal urinary diversion by way of extension of the umbilical port site. The operative time was 315 +/- 40 minutes, and the blood loss was minimal (217 +/- 29 mL). The pathologic evaluation revealed negative margins and negative lymph node involvement (mean number of nodes 16 +/- 3). All patients were discharged within 1 week (6 +/- 1 days) with minimal postoperative pain according to the visual analog pain scale (0-1 of 10). At a minimum of 2 years of follow-up (range 24-26 months), no evidence of recurrent or metastatic disease was detected. CONCLUSIONS: Laparoendoscopic single-site surgery for radical cystectomy and bilateral pelvic lymph node dissection is feasible and safe for select patients. Adequate lymph node dissection was possible through a single multichannel port. The long-term oncologic evaluation of these patients awaits; however, the preliminary outcomes have been promising.
机译:目的:报道首例腹腔镜内镜下单点手术,用于根治性膀胱切除术和双侧盆腔淋巴结清扫术。腹腔镜内镜单点手术的发展及其在尿路上皮恶性肿瘤中的应用尚未得到评估。方法:新颖,单一的多通道端口,柔性腹腔镜仪器和腹腔镜用于所有手术。符合条件的患者患有移行细胞癌,该移行细胞癌是肌肉浸润性的或膀胱内治疗难以治疗的。排除局部晚期疾病,先前的腹部或骨盆手术或放疗或需要原位重建的患者。不需要其他端口,并且使用扩展的模板进行主动脉分叉的淋巴结清扫术。结果:共3例(2男1女)行根治性膀胱切除术并双侧盆腔淋巴结清扫术。所有程序均已成功完成。所有患者均通过延长脐带口部位进行了体外尿液改道。手术时间为315 +/- 40分钟,出血量极少(217 +/- 29 mL)。病理评估显示阴性切缘和阴性淋巴结受累(平均淋巴结数目16 +/- 3)。根据视觉模拟疼痛量表(0-1 / 10),所有患者均在1周内(6 +/- 1天)出院,术后疼痛最小。至少随访2年(24-26个月),未发现复发或转移性疾病的迹象。结论:腹腔镜内镜下单部位根治性膀胱切除术和双侧盆腔淋巴结清扫术对某些患者是可行且安全的。通过单个多通道端口可以进行足够的淋巴结清扫术。这些患者需要长期的肿瘤学评估。然而,初步结果令人鼓舞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号